Aaron C Lim1, Dara G Ghahremani2, Erica N Grodin1, ReJoyce Green1, Spencer Bujarski1, Emily E Hartwell1, Kelly E Courtney3, Kent Hutchison4, Karen Miotto2, Lara A Ray5. 1. Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA. 2. Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA. 3. Department of Psychology, University of California, San Diego, San Diego, CA, USA. 4. Department of Psychology, University of Colorado, Boulder, CO, USA. 5. Department of Psychology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: lararay@psych.ucla.edu.
Abstract
BACKGROUND: Despite known genetic variation across races, studies examining pharmacogenetics of a single nucleotide polymorphism (SNP) of the mu-opioid receptor gene (OPRM1) on clinical response to naltrexone have been conducted in predominantly Caucasian samples. Evidence is mixed for pharmacogenetic OPRM1 and naltrexone effects on neural responses to alcohol cues. The current study tests the pharmacogenetic effects of naltrexone and OPRM1 on neural responses to alcohol taste cues in heavy drinkers of East Asian descent. METHODS: Participants (N = 41) completed two double-blinded and counterbalanced functional magnetic resonance imaging (fMRI) sessions: one after taking naltrexone (50 mg/day) for four days and one after taking placebo for four days. Following titration, participants completed an fMRI alcohol taste-cues task. Analyses tested effects of naltrexone, OPRM1, and their interaction in whole-brain and region of interest (ROI) analyses of functional activation and functional connectivity in response to alcohol versus water taste cues. RESULTS: We found no effects of naltrexone orOPRM1 on neural activation in whole-brain and ROI analyses, which included left and right ventral striatum (VS), anterior cingulate cortex (ACC), and orbitofrontal cortex (OFC). Naltrexone increased functional connectivity between left VS and clusters in medial prefrontal cortex, posterior cingulate gyrus, as well as right VS and occipital cortex, compared to placebo. CONCLUSIONS: Naltrexone treatment enhanced functional connectivity in a key reinforcement-related pathway during alcohol versus water taste cues, corroborating neuroimaging work with other substances. Null medication and pharmacogenetics effects on functional activation add to a mixed naltrexone literature and may underscore the modest size of these effects in East Asians.
BACKGROUND: Despite known genetic variation across races, studies examining pharmacogenetics of a single nucleotide polymorphism (SNP) of the mu-opioid receptor gene (OPRM1) on clinical response to naltrexone have been conducted in predominantly Caucasian samples. Evidence is mixed for pharmacogenetic OPRM1 and naltrexone effects on neural responses to alcohol cues. The current study tests the pharmacogenetic effects of naltrexone and OPRM1 on neural responses to alcohol taste cues in heavy drinkers of East Asian descent. METHODS: Participants (N = 41) completed two double-blinded and counterbalanced functional magnetic resonance imaging (fMRI) sessions: one after taking naltrexone (50 mg/day) for four days and one after taking placebo for four days. Following titration, participants completed an fMRI alcohol taste-cues task. Analyses tested effects of naltrexone, OPRM1, and their interaction in whole-brain and region of interest (ROI) analyses of functional activation and functional connectivity in response to alcohol versus water taste cues. RESULTS: We found no effects of naltrexone orOPRM1 on neural activation in whole-brain and ROI analyses, which included left and right ventral striatum (VS), anterior cingulate cortex (ACC), and orbitofrontal cortex (OFC). Naltrexone increased functional connectivity between left VS and clusters in medial prefrontal cortex, posterior cingulate gyrus, as well as right VS and occipital cortex, compared to placebo. CONCLUSIONS: Naltrexone treatment enhanced functional connectivity in a key reinforcement-related pathway during alcohol versus water taste cues, corroborating neuroimaging work with other substances. Null medication and pharmacogenetics effects on functional activation add to a mixed naltrexone literature and may underscore the modest size of these effects in East Asians.
Authors: V A Ramchandani; J Umhau; F J Pavon; V Ruiz-Velasco; W Margas; H Sun; R Damadzic; R Eskay; M Schoor; A Thorsell; M L Schwandt; W H Sommer; D T George; L H Parsons; P Herscovitch; D Hommer; M Heilig Journal: Mol Psychiatry Date: 2010-05-18 Impact factor: 15.992
Authors: Lara A Ray; Kelly E Courtney; Kent E Hutchison; James Mackillop; Adriana Galvan; Dara G Ghahremani Journal: Alcohol Clin Exp Res Date: 2013-07-22 Impact factor: 3.455
Authors: Francesca M Filbey; Lara Ray; Andrew Smolen; Eric D Claus; Amy Audette; Kent E Hutchison Journal: Alcohol Clin Exp Res Date: 2008-07 Impact factor: 3.455
Authors: Francesca M Filbey; Eric Claus; Amy R Audette; Michelle Niculescu; Marie T Banich; Jody Tanabe; Yiping P Du; Kent E Hutchison Journal: Neuropsychopharmacology Date: 2007-07-25 Impact factor: 7.853
Authors: Hisham Ziauddeen; Liam J Nestor; Naresh Subramaniam; Chris Dodds; Pradeep J Nathan; Sam R Miller; Bhopinder K Sarai; Kay Maltby; Disala Fernando; Liling Warren; Louise K Hosking; Dawn Waterworth; Anna Korzeniowska; Beta Win; Duncan B Richards; Lakshmi Vasist Johnson; Paul C Fletcher; Edward T Bullmore Journal: Neuropsychopharmacology Date: 2016-04-25 Impact factor: 7.853
Authors: Laurel S Morris; Kwangyeol Baek; Roger Tait; Rebecca Elliott; Karen D Ersche; Remy Flechais; John McGonigle; Anna Murphy; Liam J Nestor; Csaba Orban; Filippo Passetti; Louise M Paterson; Ilan Rabiner; Laurence Reed; Dana Smith; John Suckling; Eleanor M Taylor; Edward T Bullmore; Anne R Lingford-Hughes; Bill Deakin; David J Nutt; Barbara J Sahakian; Trevor W Robbins; Valerie Voon Journal: Addict Biol Date: 2017-02-28 Impact factor: 4.280
Authors: Aaron C Lim; ReJoyce Green; Erica N Grodin; Alexandra Venegas; Lindsay R Meredith; Suzanna Donato; Elizabeth Burnette; Lara A Ray Journal: Alcohol Clin Exp Res Date: 2020-05-14 Impact factor: 3.928
Authors: Luiza Florence; Dângela Layne Silva Lassi; Guilherme T Kortas; Danielle R Lima; Cintia de Azevedo-Marques Périco; Arthur G Andrade; Julio Torales; Antonio Ventriglio; Domenico De Berardis; João P De Aquino; João M Castaldelli-Maia Journal: Brain Sci Date: 2022-03-14